Acetylsalicylic acid lysinate

Phase 3Small molecule

MMedical University of Vienna

Acetylsalicylic acid lysinate is one of 47 small molecule programs targeting Mortality. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MortalityActive, not recruiting

Colorectal AdenomaActive, not recruiting

MortalityPhase 3

Active, not recruiting

Colorectal AdenomaPhase 3

Active, not recruiting

Competition

Competitive Landscape

108 competitors in Mortality

#DrugCompanyPhaseTrials

Winrevair

Merck & Co.

Phase 3

1 2

Mounjaro

Eli Lilly

Phase 3

1 3

Crestor

AstraZeneca

Phase 3

1 4

Deltavit

HHyundai Pharmaceutical Co., LTD.

Phase 3

2 5

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 6

Nydrazid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

1 7

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 8

Peridex

MMedline Industries

Phase 3

1 9

Prometrium

Ferring

Phase 3

1 10

Jardiance

Boehringer Ingelheim

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 3Active, not recruiting

Colorectal Adenoma

NCT02813824

Clinical

Trials by Indication[1]

Aspirin1 trial

Aspirin in Reduction of Tension II Study

Completed·LLeiden University Medical Center·Phase 4·NCT01379079·290 enrolled

Colorectal Adenoma1 trial

Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome

Active, not recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT02813824·852 enrolled

Endotoxemia1 trial

Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

Completed·RRadboud University Medical Center·N/A·NCT02612480·40 enrolled

Mortality1 trial

Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit

Terminated·MMedical University of Vienna·Phase 3·NCT02285153·15 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Acetylsalicylic acid lysinate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Acetylsalicylic acid lysinate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Acetylsalicylic acid lysinate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medical University of Vienna company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: MMedical University of Vienna

Acetylsalicylic acid lysinate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Aspirin1 trial

Colorectal Adenoma1 trial

Endotoxemia1 trial

Mortality1 trial

References

Drug Info

Quick Facts

Related News